Skip to main content
Clinical Trials/NL-OMON32392
NL-OMON32392
Completed
Phase 2

A prospective study to evaluate the safety and efficacy of AdvaCoat Mx sinus gel for treatment of chronic rhinosinusitis without nasal polyps. - AdvaCoat Mx sinus gel study for chronic rhinosinusitis without nasal polyps

Carbylan BioSurgery, Inc.0 sites49 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Chronic rhinosinusitis
Sponsor
Carbylan BioSurgery, Inc.
Enrollment
49
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Carbylan BioSurgery, Inc.

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis of CRS defined as:
  • \- Symptoms present for \>12 consecutive weeks
  • \- At least two of the following:
  • \* Anterior and/or posterior mucoid drainage
  • \* Nasal congestion
  • \* Facial pain / pressure / fullness
  • \- Both of the following:
  • \* Nasal endoscopic examination confirming inflammation and/or edema of the ostiomeatal complex without the presence of polyps and/or previous sinus surgical procedures
  • \* Evidence of CRS on CT (minimum score of 4 with at least two points coming from the sinuses; reference Table 1 for grading scale);2\. Average score of 40\-80 mm on the Patient Subjective Symptom Score (PSSS) at the end of the run\-in period
  • 3\. 18 \- 85 years of age

Exclusion Criteria

  • 1\. Unilateral sinus disease
  • 2\. Evidence of polyps within or beyond the middle meatus by nasal endoscopy
  • 3\. Samter\*s Triad
  • 4\. Previous or planned nasal or sinus surgery, including sinuplasty
  • 5\. Steroid dependent asthma
  • 6\. A known sensitivity to hyaluronan products, corticosteroids or any excipients contained within the formulation of Kenacort A\-10
  • 7\. Cystic fibrosis or any immune deficiency that may interfere with wound healing
  • 8\. Any disease or condition that interferes with safe completion of initial or follow\-up assessments
  • 9\. Anatomical abnormalities within middle meatus by endoscopy
  • 10\. Current evidence of sinus mucocele

Outcomes

Primary Outcomes

Not specified

Similar Trials